Roxfur-LA 1.25 Gm Inj. Therapeutics

Lyophilized ceftiofur sodium with slow release depot action which increase stability and performance of drug which are active against pathogens.

Size: 1.25 gm

Key Features

Lyophilized - Increase Stability, Purity & Performance of Drug.
Long Acting - N-M-2 Pyrrolidone helps to form depot & extend release of Ceftiofur Sodium.
Double Action - Both Ceftiofur & Desfuroyl Ceftiofur are active against pathogens.
Broad Spectrum & Bactericidal - Effective against RTI & UTI infection - Contains Amino Thiazole ring
Low MIC Level
Zero Day Milk Withdrawal Period

Composition

Each Vial Contains:	--
Sterile Ceftiofur Sodium I.P.	--
eq. to anhydrous Ceftiofur	1.25 gm
Each vial (Part B) Per ml contains:	--
N-Methyl 2-pyrrolidone	300 mg
Benzyl Alcohol I.P.	10 mg
Aqueous Base	q.s.

Indications

Presentation

1.25 gm Ceftiofur vial with 20 ml Long Acting Diluent (LAD) water for Injection with 20 ml sterile syringe & needle

Related Product